• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

OtherGlobal Hepatitis B and C Diagnostics Market Size, Status and Forecast 2025

  • RnM2315768
  • |
  • 8 August, 2018
  • |
  • Global
  • |
  • 102 pages
  • |
  • QYResearch
  • |
  • Other

This report studies the global Hepatitis B and C Diagnostics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Hepatitis B and C Diagnostics market by companies, region, type and end-use industry.

Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.
The increasing demand for molecular diagnostic of HBV (hepatitis B virus) and HCV (hepatitis C virus) infections is one of the primary drivers for the growth of this market. Molecular diagnosis simplifies sample preparation for high-volume testing and includes identification and profiling of causative agents of infection and the quantification of pathogens to monitor durability of therapy; thus, resulting in sales of around 60% of the overall molecular diagnosis market. Additionally, new companies are also focusing on the development of new products, which, in turn, is expected to change market dynamics for the diagnosis of HBV and HCV infections. For instance, Cepheid recently announced a quantitative test that offers on-demand molecular testing for confirmation of infection and monitoring of HCV and has obtained CE-IVD (in vitro diagnostics) status under the European Directive on in-vitro diagnostic medical devices, making it one of the leading platforms for molecular diagnosis.
Increasing incidence of HBV and HCV infections in the Americas will contribute to the growth of the diagnostic market. The Americas will dominate the market, accounting for half of the total market share by 2023. The recent increase in blood transfusion will result in the adoption of third-generation hepatitis C diagnostic tests like HCV enzyme immunoassay that contribute to the growth of the market in this region. Also, the implementation of biomarker-based POC (point-of-care) tests initiated by the government and non-profit organizations, is also expected to drive the market growth as the products are highly accessible and easy to use.
In 2017, the global Hepatitis B and C Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global top players, covered
Roche Diagnostics
Abbott
Siemens
Qiagen
Alere
bioMérieux
Cepheid
Chembio Diagnostics
DiaSorin
Enzo Life Sciences
Hologic
MedMira
OraSure Technologies
Quest Diagnostics
Quidel Corp
Randox Laboratories

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Market segment by Type, the product can be split into
Hepatitis B
Hepatitis C

Market segment by Application, split into
Immunodiagnostics
Nucleic Acid Test (NAT)

The study objectives of this report are:
To study and forecast the market size of Hepatitis B and C Diagnostics in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Hepatitis B and C Diagnostics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Hepatitis B and C Diagnostics Manufacturers
Hepatitis B and C Diagnostics Distributors/Traders/Wholesalers
Hepatitis B and C Diagnostics Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Hepatitis B and C Diagnostics market, by end-use.
Detailed analysis and profiles of additional market players.


Table of Contents

Global Hepatitis B and C Diagnostics Market Size, Status and Forecast 2025
1 Industry Overview of Hepatitis B and C Diagnostics
1.1 Hepatitis B and C Diagnostics Market Overview
1.1.1 Hepatitis B and C Diagnostics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Hepatitis B and C Diagnostics Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Hepatitis B and C Diagnostics Market by Type
1.3.1 Hepatitis B
1.3.2 Hepatitis C
1.4 Hepatitis B and C Diagnostics Market by End Users/Application
1.4.1 Immunodiagnostics
1.4.2 Nucleic Acid Test (NAT)

2 Global Hepatitis B and C Diagnostics Competition Analysis by Players
2.1 Hepatitis B and C Diagnostics Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Roche Diagnostics
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
3.2 Abbott
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
3.3 Siemens
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
3.4 Qiagen
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
3.5 Alere
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
3.6 bioMérieux
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
3.7 Cepheid
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
3.8 Chembio Diagnostics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
3.9 DiaSorin
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
3.10 Enzo Life Sciences
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Hepatitis B and C Diagnostics Revenue (Million USD) (2013-2018)
3.11 Hologic
3.12 MedMira
3.13 OraSure Technologies
3.14 Quest Diagnostics
3.15 Quidel Corp
3.16 Randox Laboratories

4 Global Hepatitis B and C Diagnostics Market Size by Type and Application (2013-2018)
4.1 Global Hepatitis B and C Diagnostics Market Size by Type (2013-2018)
4.2 Global Hepatitis B and C Diagnostics Market Size by Application (2013-2018)
4.3 Potential Application of Hepatitis B and C Diagnostics in Future
4.4 Top Consumer/End Users of Hepatitis B and C Diagnostics

5 United States Hepatitis B and C Diagnostics Development Status and Outlook
5.1 United States Hepatitis B and C Diagnostics Market Size (2013-2018)
5.2 United States Hepatitis B and C Diagnostics Market Size and Market Share by Players (2013-2018)
5.3 United States Hepatitis B and C Diagnostics Market Size by Application (2013-2018)

6 Europe Hepatitis B and C Diagnostics Development Status and Outlook
6.1 Europe Hepatitis B and C Diagnostics Market Size (2013-2018)
6.2 Europe Hepatitis B and C Diagnostics Market Size and Market Share by Players (2013-2018)
6.3 Europe Hepatitis B and C Diagnostics Market Size by Application (2013-2018)

7 China Hepatitis B and C Diagnostics Development Status and Outlook
7.1 China Hepatitis B and C Diagnostics Market Size (2013-2018)
7.2 China Hepatitis B and C Diagnostics Market Size and Market Share by Players (2013-2018)
7.3 China Hepatitis B and C Diagnostics Market Size by Application (2013-2018)

8 Japan Hepatitis B and C Diagnostics Development Status and Outlook
8.1 Japan Hepatitis B and C Diagnostics Market Size (2013-2018)
8.2 Japan Hepatitis B and C Diagnostics Market Size and Market Share by Players (2013-2018)
8.3 Japan Hepatitis B and C Diagnostics Market Size by Application (2013-2018)

9 Southeast Asia Hepatitis B and C Diagnostics Development Status and Outlook
9.1 Southeast Asia Hepatitis B and C Diagnostics Market Size (2013-2018)
9.2 Southeast Asia Hepatitis B and C Diagnostics Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Hepatitis B and C Diagnostics Market Size by Application (2013-2018)

10 India Hepatitis B and C Diagnostics Development Status and Outlook
10.1 India Hepatitis B and C Diagnostics Market Size (2013-2018)
10.2 India Hepatitis B and C Diagnostics Market Size and Market Share by Players (2013-2018)
10.3 India Hepatitis B and C Diagnostics Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Hepatitis B and C Diagnostics Market Size (Value) by Regions (2018-2025)
11.1.1 United States Hepatitis B and C Diagnostics Revenue and Growth Rate (2018-2025)
11.1.2 Europe Hepatitis B and C Diagnostics Revenue and Growth Rate (2018-2025)
11.1.3 China Hepatitis B and C Diagnostics Revenue and Growth Rate (2018-2025)
11.1.4 Japan Hepatitis B and C Diagnostics Revenue and Growth Rate (2018-2025)
11.1.5 Southeast Asia Hepatitis B and C Diagnostics Revenue and Growth Rate (2018-2025)
11.1.6 India Hepatitis B and C Diagnostics Revenue and Growth Rate (2018-2025)
11.2 Global Hepatitis B and C Diagnostics Market Size (Value) by Type (2018-2025)
11.3 Global Hepatitis B and C Diagnostics Market Size by Application (2018-2025)

12 Hepatitis B and C Diagnostics Market Dynamics
12.1 Hepatitis B and C Diagnostics Market Opportunities
12.2 Hepatitis B and C Diagnostics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Hepatitis B and C Diagnostics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Hepatitis B and C Diagnostics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Hepatitis B and C Diagnostics. Industry analysis & Market Report on Hepatitis B and C Diagnostics is a syndicated market report, published as Global Hepatitis B and C Diagnostics Market Size, Status and Forecast 2025. It is complete Research Study and Industry Analysis of Hepatitis B and C Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,300.00
$6,600.00
2,215.95
4,431.90
3,036.66
6,073.32
399,762.00
799,524.00
218,834.22
437,668.44
Add To Cart Credit card Logo

Related Reports


Reason to Buy